Macular degeneration is a leading cause of vision loss for people over 50, but there are ways to help protect your eyesight.

Our vision declines as we age leading to the development of various eye conditions such as presbyopia cataracts and glaucoma ...

Macular degeneration is one of the leading causes of vision loss, affecting millions worldwide, especially those over 60.

Susvimo is the first and only FDA-approved treatment shown to maintain vision in people with diabetic macular edema with ...

The unique challenges, and need for awareness, of age-related macular degeneration (AMD) is now formally recognized in Canada ...

The company offers year-round educational services on the conditions, using this month, in particular, to guide patients to ...

Collaboration between TLI and AMDF underscores a shared commitment to making a meaningful difference in the lives of those affected by AMD. Together, TLI and AMDF are dedicated to advancing awareness, ...

Roche’s Susvimo receives US FDA approval for the treatment of diabetic macular edema: Basel Thursday, February 6, 2025, 11:00 Hrs [IST] Roche announced that the US Food and Drug ...

But in many cases, it can certainly help with vision problems, SaveHealth reports. Conditions like glaucoma, macular degeneration, and corneal abrasions sometimes require medications to cure the ...

The U.S. Food and Drug Administration (FDA) has approved ranibizumab injection (Susvimo, 100 mg/mL; Genentech) for the ...

The global macular degeneration treatment market size was valued at USD 10.06 billion in 2024 and it is projected to reach ...